Clinical Trial Update: Omega-3 Supplementation and Immunotherapy in Gastric Cancer: A Phase II Trial [Phase 2]

View source ↗

Summary

A Phase II trial examining omega-3 supplementation in combination with immunotherapy for gastric cancer (Stage III) is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Immunotherapy (unspecified)
• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Gastric Cancer Stage III | Phase 2 | Status: NOT_YET_RECRUITING